Townsquare Capital LLC Buys 1,562 Shares of STERIS plc (NYSE:STE)

Townsquare Capital LLC grew its holdings in shares of STERIS plc (NYSE:STE - Free Report) by 8.6% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 19,706 shares of the medical equipment provider's stock after buying an additional 1,562 shares during the period. Townsquare Capital LLC's holdings in STERIS were worth $4,051,000 as of its most recent SEC filing.

Several other large investors have also added to or reduced their stakes in the stock. Avalon Trust Co bought a new stake in shares of STERIS during the 4th quarter valued at about $30,000. Human Investing LLC bought a new position in shares of STERIS in the 4th quarter worth approximately $31,000. Anfield Capital Management LLC lifted its stake in shares of STERIS by 100.0% in the 4th quarter. Anfield Capital Management LLC now owns 182 shares of the medical equipment provider's stock valued at $37,000 after purchasing an additional 91 shares during the period. Central Pacific Bank Trust Division grew its stake in STERIS by 65.5% in the fourth quarter. Central Pacific Bank Trust Division now owns 192 shares of the medical equipment provider's stock worth $39,000 after purchasing an additional 76 shares during the period. Finally, Manchester Capital Management LLC lifted its position in STERIS by 182.7% during the fourth quarter. Manchester Capital Management LLC now owns 212 shares of the medical equipment provider's stock valued at $44,000 after buying an additional 137 shares during the period. Institutional investors own 94.69% of the company's stock.

Analyst Upgrades and Downgrades

Several research analysts recently issued reports on STE shares. JMP Securities reiterated a "market outperform" rating and issued a $265.00 price target on shares of STERIS in a research note on Thursday, April 10th. Stephens reaffirmed an "overweight" rating and set a $240.00 price objective on shares of STERIS in a research report on Thursday, February 6th. Piper Sandler boosted their target price on STERIS from $260.00 to $265.00 and gave the stock an "overweight" rating in a report on Monday, February 3rd. Finally, Needham & Company LLC restated a "hold" rating on shares of STERIS in a report on Monday, April 7th. One investment analyst has rated the stock with a hold rating and five have given a buy rating to the stock. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average target price of $258.75.

STERIS Stock Up 1.1 %

Shares of STERIS stock traded up $2.51 on Friday, reaching $222.53. The company's stock had a trading volume of 451,315 shares, compared to its average volume of 527,766. STERIS plc has a 52 week low of $198.13 and a 52 week high of $248.24. The firm's fifty day simple moving average is $222.48 and its two-hundred day simple moving average is $218.98. The company has a quick ratio of 1.40, a current ratio of 2.13 and a debt-to-equity ratio of 0.32. The company has a market capitalization of $21.86 billion, a price-to-earnings ratio of 47.25 and a beta of 0.87.

STERIS (NYSE:STE - Get Free Report) last issued its earnings results on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share for the quarter, missing analysts' consensus estimates of $2.33 by ($0.01). STERIS had a return on equity of 13.91% and a net margin of 8.66%. Equities analysts anticipate that STERIS plc will post 9.08 earnings per share for the current year.

STERIS Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, March 21st. Shareholders of record on Thursday, February 20th were given a $0.57 dividend. This represents a $2.28 dividend on an annualized basis and a yield of 1.02%. The ex-dividend date was Thursday, February 20th. STERIS's dividend payout ratio (DPR) is presently 48.41%.

About STERIS

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.